Attached files
| file | filename |
|---|---|
| EX-21.1 - EXHIBIT 21.1 - EKSO BIONICS HOLDINGS, INC. | v460534_ex21-1.htm |
| EX-32.1 - EXHIBIT 32.1 - EKSO BIONICS HOLDINGS, INC. | v460534_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - EKSO BIONICS HOLDINGS, INC. | v460534_ex31-1.htm |
| EX-31.2 - EXHIBIT 31.2 - EKSO BIONICS HOLDINGS, INC. | v460534_ex31-2.htm |
| EX-23.1 - EXHIBIT 23.1 - EKSO BIONICS HOLDINGS, INC. | v460534_ex23-1.htm |
| 10-K - FORM 10-K - EKSO BIONICS HOLDINGS, INC. | v460534_10k.htm |
Exhibit 32.2
CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO
18 U.S.C. SECTION 1350
In connection with the Annual Report on Form 10-K of Ekso Bionics Holdings, Inc. (the “Company”), for the fiscal year ended December 31, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Maximilian Scheder-Bieschin, Chief Financial Officer and principal financial officer, hereby certify as of the date hereof, solely for purposes of 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and |
| (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. |
Dated: March 14, 2017
| /s/ Maximilian Scheder-Bieschin | |
| Maximilian Scheder-Bieschin | |
| Principal Financial Officer |